October 17 Roundup: Mutual Fund News & Opinion An Opening for Biotech Mutual Funds? What a surprise! Some drug companies discovered that increasing the price of a life-saving drug by hundreds of percent in one swoop will alienate customers and regulators. Biotech stocks, and

Read More